Veracyte, Inc.
VCYT
Revenue
114.43M
▲17.58M▲18.16%
3 Months ChangeAssets
1.23B
▲34.25M▲2.85%
3 Months ChangeLiabilities
101.80M
▲20.38M▲25.03%
3 Months ChangeFree Cash Flow
-11.10M
▼-7.94M▼-250.71%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-04
Form 8-K
ID: 0001384101-24-000133
2024-08-07
Form 10-Q
ID: 0001384101-24-000118
2024-08-06
Form 8-K
ID: 0001384101-24-000116
2024-06-13
Form 8-K
ID: 0001384101-24-000093
2024-05-08
Form 10-Q
ID: 0001384101-24-000067
2024-05-07
Form 8-K
ID: 0001384101-24-000064
2024-03-22
Form 8-K
ID: 0001193125-24-075385
2024-02-29
Form 8-K
ID: 0001193125-24-053689
2024-02-22
Form 8-K
ID: 0001384101-24-000013
2024-02-13
Form 8-K
ID: 0001384101-24-000007